Assessment of the Immune-mediated Protection and Pathology Conferred by Candidate Filovirus Vaccines
$626,442Y01FY2017AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This agreement will utilize animal models to explore the cause of immunopathology in the microenvironment of the vaccinated animal lung following infection with Ebola virus via the aerosol route.
View original record on NIH RePORTER →